Graft Rejection Scoring

Graft Rejection Scoring separates severity by weighing the extent of immune-related changes rather than treating all abnormal findings equally. Limited inflammation may correspond to a lower grade, whereas broader tissue injury, vascular damage, or declining graft function supports a more advanced grade. This stratification helps indicate whether the response is relatively contained or associated with substantial graft compromise.

The assessment focuses on evidence that recipient immune cells recognize donor antigens and injure the graft. Inflammation reflects immune-cell activity, vascular damage indicates injury to graft blood vessels, and impaired graft function shows a physiological consequence. Considering these findings together links the underlying immune response with structural damage and functional loss, strengthening interpretation of the assigned grade.

Each measure captures a different aspect of rejection. Inflammation provides evidence of immune activity, vascular injury shows damage to an important graft compartment, and functional decline indicates that the tissue is no longer performing normally. Their combined interpretation reduces reliance on a single observation and gives the score greater value for judging the overall severity of immune-mediated injury.

An assessment begins by collecting the available clinical, laboratory, and biopsy-based findings. These observations are then compared with the criteria for defined grades, followed by assignment of the grade that best represents the observed injury. Repeating the same process at later time points allows investigators or clinicians to determine whether rejection is stable, worsening, or improving.

Scores provide a structured way to compare graft status before and after immunosuppressive treatment. A lower subsequent grade may indicate reduced immune-mediated injury, while a persistent or higher grade suggests that substantial rejection remains. Tracking these changes over time supports treatment evaluation and gives clinicians and researchers a consistent outcome measure rather than relying only on isolated observations.

Standardized grades create a common language for reporting graft injury across clinical assessments and experiments. They help distinguish outcomes among treatment groups, support comparisons between emerging therapies, and improve communication between researchers and clinicians. In immunology research, the scores also connect donor-antigen recognition with measurable tissue and functional consequences, helping interpret how immune responses affect transplant outcomes.